|
Impact of chemotherapy alone or in combination with an anti-angiogenic on the immune tumor microenvironment (TME) of ovarian cancer: Data from the randomized CHIVA trial (a GINECO –GINEGEPS study). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Isabelle Laure Ray-Coquard |
Honoraria - Abbvie; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Genmab; MSD Oncology; Pfizer; PharmaMar; Roche; Tesaro |
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; MSD Oncology; Pfizer; PharmaMar; Roche; Tesaro |
Research Funding - Bristol-Myers Squibb; MSD Oncology |
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro |
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; French National Cancer Institute (INCA) |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro |
Research Funding - Astellas Pharma; Janssen |
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro |
|
|
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline/Tesaro; Olympus; RanD Biotech |
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche Pharma AG |
|
|
Honoraria - AstraZeneca; GlaxoSmithKline; Tesaro |
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Incyte; Merck; Pfizer/EMD Serono; Roche; TESARO |
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro |
Other Relationship - Arcagy-Gineco |
|
|
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Roche; Tesaro |
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro |
|
|
No Relationships to Disclose |